Literature DB >> 9588673

Methodology of a novel myocardial viability protocol.

A E Iskandrian, E Acio.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9588673     DOI： 10.1016/s1071-3581(98)90204-5

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  23 in total

1.  Pathophysiology of chronic left ventricular dysfunction. New insights from the measurement of absolute myocardial blood flow and glucose utilization.

Authors:  N V Marinho; B E Keogh; D C Costa; A A Lammerstma; P J Ell; P G Camici
Journal:  Circulation       Date:  1996-02-15       Impact factor: 29.690

Review 2.  Pathophysiological mechanisms of chronic reversible left ventricular dysfunction due to coronary artery disease (hibernating myocardium).

Authors:  P G Camici; W Wijns; M Borgers; R De Silva; R Ferrari; J Knuuti; A A Lammertsma; A J Liedtke; G Paternostro; S F Vatner
Journal:  Circulation       Date:  1997-11-04       Impact factor: 29.690

3.  Myocardial viability: contractile reserve or cell membrane integrity?

Authors:  V Dilsizian
Journal:  J Am Coll Cardiol       Date:  1996-08       Impact factor: 24.094

Review 4.  Myocardial viability: methods of assessment and clinical relevance.

Authors:  A S Iskandrian; J Heo; H R Schelbert
Journal:  Am Heart J       Date:  1996-12       Impact factor: 4.749

5.  Nitroglycerin-augmented 201T1 reinjection enhances detection of reversible myocardial hypoperfusion. A randomized, double-blind, parallel, placebo-controlled trial.

Authors:  Z X He; R Medrano; J T Hays; J J Mahmarian; M S Verani
Journal:  Circulation       Date:  1997-04-01       Impact factor: 29.690

6.  Factors influencing regional myocardial contractile response to inotropic stimulation. Analysis in humans with stable ischemic heart disease.

Authors:  H A Skopicki; S A Abraham; N J Weissman; A K Mukerjee; N M Alpert; A J Fischman; M H Picard; H Gewirtz
Journal:  Circulation       Date:  1996-08-15       Impact factor: 29.690

7.  Effects of dobutamine stimulation on myocardial blood flow, glucose metabolism, and wall motion in normal and dysfunctional myocardium.

Authors:  K T Sun; J Czernin; J Krivokapich; Y K Lau; M Böttcher; G Maurer; M E Phelps; H R Schelbert
Journal:  Circulation       Date:  1996-12-15       Impact factor: 29.690

8.  Assessment of reversible dyssynergic segments after acute myocardial infarction: Dobutamine echocardiography versus thallium-201 single photon emission computed tomography.

Authors:  C Le Feuvre; N Baubion; N Aubry; J P Metzger; P de Vernejoul; A Vacheron
Journal:  Am Heart J       Date:  1996-04       Impact factor: 4.749

9.  Effects of dobutamine stress on myocardial blood flow, 99mTc sestamibi uptake, and systolic wall thickening in the presence of coronary artery stenoses: implications for dobutamine stress testing.

Authors:  D A Calnon; D K Glover; G A Beller; G Vanzetto; W H Smith; D D Watson; M Ruiz
Journal:  Circulation       Date:  1997-10-07       Impact factor: 29.690

10.  Assessment of myocardial viability in patients with chronic coronary artery disease. Rest-4-hour-24-hour 201Tl tomography versus dobutamine echocardiography.

Authors:  P Perrone-Filardi; L Pace; M Prastaro; F Squame; S Betocchi; A Soricelli; F Piscione; C Indolfi; T Crisci; M Salvatore; M Chiariello
Journal:  Circulation       Date:  1996-12-01       Impact factor: 29.690
View more
  2 in total

1.  Prediction of left ventricular wall motion recovery after acute myocardial infarction by Tl-201 gated SPECT: incremental value of integrated contractile reserve assessment.

Authors:  Marcus Vinicius Simões; Oswaldo César de Almeida-Filho; Antonio Osvaldo Pintya; Alexandre Baldini de Figueiredo; Cleide Marques Antloga; Fernando Vilela Salis; Nadia de Paula Batista; Moysés de Oliveira Lima-Filho; Benedito Carlos Maciel; José Antonio Marin-Neto
Journal:  J Nucl Cardiol       Date:  2002 May-Jun       Impact factor: 5.952

2.  Nitrate-enhanced gated technetium 99m sestamibi SPECT for evaluating regional wall motion at baseline and during low-dose dobutamine infusion in patients with chronic coronary artery disease and left ventricular dysfunction: comparison with two-dimensional echocardiography.

Authors:  M Leoncini; G Marcucci; R Sciagrà; F Frascarelli; A M Traini; D Mondanelli; M Magni; L Bini; F Bellandi; A Mennuti; R P Dabizzi
Journal:  J Nucl Cardiol       Date:  2000 Sep-Oct       Impact factor: 5.952
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.